Sugi Predict

Sugi Predict / Compounds / SCHEMBL31289567

SCHEMBL31289567

SCHEMBL31289567

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ BDKRB2 P30411 3/20 0.59
▸ OPRM1 P35372 11/20 0.54
▸ OPRD1 P41143 4/20 0.54
▸ NMUR2 Q9GZQ4 4/20 0.54
▸ NMUR1 Q9HB89 4/20 0.54
▸ OPRK1 P41145 7/20 0.54
▸ F2 P00734 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31289576 0.95 BDKRB2 (0.58) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL31289572 0.95 BDKRB2 (0.66) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL31289571 0.95 BDKRB2 (0.66) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL30672603 0.95 BDKRB2 (0.66) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL25335885 0.93 BDKRB2 (0.68) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL30526215 0.93 BDKRB2 (0.68) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL30549403 0.92 BDKRB2 (0.63) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL29496923 0.92 BDKRB2 (0.62) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL30526200 0.90 BDKRB2 (0.61) BDKRB2OPRM1OPRD1NMUR2NMUR1
SCHEMBL30672572 0.90 BDKRB2 (0.72) BDKRB2OPRM1OPRD1NMUR2NMUR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024259525-A1 NANOPARTICLES COMPRISING N,N,N-TRIMETHYL CHITOSAN COATED WITH PEPTIDE AGONISTS OF KININ B1 OR B2 AND/OR PEPTIDE ANTAGONISTS OF KININ B1 FOR TRANSVASCULAR DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA SANTE ET HUMAINES, S.E.C. (CA) 2024-12-26 — — WO claimed
WO-2024259525-A1 NANOPARTICLES COMPRISING N,N,N-TRIMETHYL CHITOSAN COATED WITH PEPTIDE AGONISTS OF KININ B1 OR B2 AND/OR PEPTIDE ANTAGONISTS OF KININ B1 FOR TRANSVASCULAR DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA SANTE ET HUMAINES, S.E.C. (CA) 2024-12-26 — — WO disclosed
Send feedback